Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study (PsoCOVID)

Kevin V. Kweea Department of Dermatology/DermaTeam Research, Bravis Hospital, Roosendaal, The NetherlandsView further author information

Jean-Luc Murkb Elisabeth Tweesteden Hospital, Microvida, Tilburg, The Netherlands

Qiqi Yina Department of Dermatology/DermaTeam Research, Bravis Hospital, Roosendaal, The NetherlandsView further author information

M. Birgitte Vischc Department of Dermatology, Rijnstate Hospital, Arnhem, The NetherlandsView further author information

Linda Davidsond Independent Infectious Disease specialist, Nijmegen, The NetherlandsView further author information

Elke M. G. J. de Jonge Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands

Juul M. P. A. van den Reeke Department of Dermatology, Radboud University Medical Center, Nijmegen, The NetherlandsView further author information

Milan Tjioea Department of Dermatology/DermaTeam Research, Bravis Hospital, Roosendaal, The NetherlandsCorrespondence[email protected]
View further author information

Your download is now in progress and you may close this window